CAMLINFINENSECamlin Fine Sciences LimitedMinimalNeutral
Announced Wed, 29 Apr · 12:50 IST

Infinity Direct Capital has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

CAMLINFINE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.4%1-day move
₹124.40
prior close
₹125.56
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3+0.0-0.6-0.6+2.4+5.8+4.6+10.2+9.6+1.1-1.3-1.5+4.4
Up moveDown movePending
AI summary

Infinity Direct Capital, a shareholder of Camlin Fine Sciences, has submitted a declaration to the stock exchanges confirming that it has not created any new encumbrance (such as pledge or lien) on its shares in the company during the financial year ended March 31, 2026. The filing was signed by Shewinrao Ladkoo, Director, from Ebene, Mauritius, indicating the entity is a foreign-registered shareholder, likely part of the promoter group. The declaration was copied to the company's Audit Committee and Company Secretary as a matter of regulatory compliance.

Likely market impact

This is a routine annual compliance filing with no material business or financial impact. The absence of new encumbrances is a neutral-to-mildly-positive signal for retail investors, as it suggests the shareholder is not under liquidity pressure requiring pledging of shares as collateral.